You can watch VINCW and buy or sell other stocks, options, and ETFs commission-free!
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd is headquartered in Palo Alto, CA. The listed name for VINCW is Vincerx Pharma, Inc. Warrant.
Ahmed Hamdy, MD
Palo Alto, California
52 Week High
52 Week Low